{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T01:35:26Z","timestamp":1789176926871,"version":"build-2803163510"},"reference-count":63,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T00:00:00Z","timestamp":1777680000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Small renal masses (SRMs) usually have a favorable prognosis. Many studies have shown that cancer-specific survival (CSS) is comparable among various treatment options, such as partial nephrectomy, percutaneous thermal ablation, stereotactic body radiotherapy, and active surveillance (AS). Therefore, the choice of treatment should be based on patient background and tumor characteristics rather than on oncologic concerns alone. Important patient factors include age, comorbidities, renal function, and life expectancy. Tumor size, growth rate, and anatomical location also influence this decision. In older or frail patients, immediate intervention may represent overtreatment, as the risk of periprocedural complications and renal function loss may outweigh the limited oncological benefit. Recent AS studies have demonstrated excellent CSS and very low metastatic rates; however, many of these prospective cohorts included patients with limited life expectancies and relatively short follow-up periods, which limit their generalizability. This review summarizes the current evidence regarding local treatment options and surveillance strategies for SRMs, focusing on oncologic outcomes, renal function, and patient selection. Finally, we highlight the rationale and design of the ongoing JCOG2409 prospective comparative study in medically operable adults aged \u226575\u00a0years with a solitary renal mass that evaluates standardized AS versus upfront interventions.<\/jats:p>","DOI":"10.1093\/jjco\/hyag069","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T11:44:51Z","timestamp":1776253491000},"page":"931-939","source":"Crossref","is-referenced-by-count":1,"title":["Optimizing management of small renal masses: a patient-centered approach to minimize overtreatment"],"prefix":"10.1093","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-9008-6356","authenticated-orcid":false,"given":"Goshi","family":"Kitano","sequence":"first","affiliation":[{"name":"Department of Urology, Aichi Cancer Center , 1-1 Kanokoden, Chikusa-ku, Nagoya, Aichi JP 464-861,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4150-9631","authenticated-orcid":false,"given":"Takahiro","family":"Kojima","sequence":"additional","affiliation":[{"name":"Department of Urology, Aichi Cancer Center , 1-1 Kanokoden, Chikusa-ku, Nagoya, Aichi JP 464-861,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Osawa","sequence":"additional","affiliation":[{"name":"Department of Urology and Molecular Oncology, Niigata University Graduate School of Medical and Dental Sciences , 1-757 Asahimachi-dori, Chuo-ku, Niigata, Niigata JP 951-8510,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruka","family":"Miyata","sequence":"additional","affiliation":[{"name":"Department of Urology, Hokkaido University Hospital , Kita 14, Nishi 5, Kita-ku, Sapporo, Hokkaido JP 060-8648,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5899-1738","authenticated-orcid":false,"given":"Kazuyuki","family":"Numakura","sequence":"additional","affiliation":[{"name":"Department of Renal and Urologic Surgery Asahikawa, Medical University, 2-1-1-1 Midorigaoka-higashi, Asahikawa, Hokkaido JP 078-8510, \u00a0","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Kitamura","sequence":"additional","affiliation":[{"name":"Department of Urology, Faculty of Medicine, University of Toyama , 2630 Sugitani, Toyama, Toyama JP 930-0194,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,5,2]]},"reference":[{"key":"2026080510413016300_ref1","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/s41585-023-00848-6","article-title":"The evolving management of small renal masses","volume":"21","author":"Wang","year":"2024","journal-title":"Nat Rev Urol"},{"key":"2026080510413016300_ref2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"2026080510413016300_ref3","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.eururo.2018.08.036","article-title":"Epidemiology of renal cell carcinoma","volume":"75","author":"Capitanio","year":"2019","journal-title":"Eur Urol"},{"key":"2026080510413016300_ref4","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.eururo.2022.08.019","article-title":"Epidemiology of renal cell carcinoma: 2022 update","volume":"82","author":"Bukavina","year":"2022","journal-title":"Eur Urol"},{"key":"2026080510413016300_ref5","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3747\/co.v16i0.409","article-title":"Natural history and management of small renal masses","volume":"16","author":"Abou Youssif","year":"2009","journal-title":"Curr Oncol"},{"key":"2026080510413016300_ref6","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1097\/MOU.0b013e3283542bc5","article-title":"The emerging role of percutaneous biopsy in diagnosis and management of small renal masses","volume":"22","author":"Yap","year":"2012","journal-title":"Curr Opin Urol"},{"key":"2026080510413016300_ref7","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1159\/000444332","article-title":"Nephron sparing surgery for renal mass: is there any difference between oncocytoma and malignant lesions","volume":"98","author":"Bahouth","year":"2017","journal-title":"Urol Int"},{"key":"2026080510413016300_ref8","doi-asserted-by":"publisher","first-page":"W178","DOI":"10.2214\/AJR.12.8776","article-title":"Renal epithelioid angiomyolipoma: imaging characteristics in nine cases with radiologic-pathologic correlation and review of the literature","volume":"200","author":"Froemming","year":"2013","journal-title":"AJR Am J Roentgenol"},{"key":"2026080510413016300_ref9","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.1002\/jum.15946","article-title":"Etiology of small echogenic renal masses","volume":"41","author":"Kwong","year":"2022","journal-title":"J Ultrasound Med"},{"key":"2026080510413016300_ref10","doi-asserted-by":"publisher","first-page":"389","DOI":"10.23736\/S0393-2249.20.03870-9","article-title":"Triggers for delayed intervention in patients with small renal masses undergoing active surveillance: a systematic review","volume":"72","author":"Campi","year":"2020","journal-title":"Minerva Urol Nefrol"},{"key":"2026080510413016300_ref11","doi-asserted-by":"publisher","first-page":"3591","DOI":"10.1200\/JCO.2018.79.2341","article-title":"Current Management of Small Renal Masses, including patient selection, renal tumor biopsy, active surveillance, and thermal ablation","volume":"36","author":"Sanchez","year":"2018","journal-title":"J Clin Oncol"},{"key":"2026080510413016300_ref12","doi-asserted-by":"publisher","first-page":"103018","DOI":"10.1016\/j.autrev.2021.103018","article-title":"Current clinical and therapeutic approach to tumour-like mass lesions in granulomatosis with polyangiitis","volume":"21","author":"Padoan","year":"2022","journal-title":"Autoimmun Rev"},{"key":"2026080510413016300_ref13","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.urology.2004.02.007","article-title":"Elective open nephron-sparing surgery for renal masses: single-center experience with 129 consecutive patients","volume":"64","author":"Marszalek","year":"2004","journal-title":"Urology."},{"key":"2026080510413016300_ref14","doi-asserted-by":"publisher","first-page":"E118","DOI":"10.5489\/cuaj.252","article-title":"Extensive renal infarction following percutaneous biopsy of a small renal mass: a case report","volume":"7","author":"Abourbih","year":"2013","journal-title":"Can Urol Assoc J"},{"key":"2026080510413016300_ref15","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.juro.2017.04.100","article-title":"Renal mass and localized renal cancer: AUA guideline","volume":"198","author":"Campbell","year":"2017","journal-title":"J Urol"},{"key":"2026080510413016300_ref16","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.juro.2016.04.081","article-title":"Management of renal masses and localized renal cancer: systematic review and meta-analysis","volume":"196","author":"Pierorazio","year":"2016","journal-title":"J Urol"},{"key":"2026080510413016300_ref17","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.euf.2019.06.002","article-title":"The emerging role of stereotactic ablative radiotherapy for primary renal cell carcinoma: a systematic review and meta-analysis","volume":"5","author":"Correa","year":"2019","journal-title":"Eur Urol Focus"},{"key":"2026080510413016300_ref18","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1016\/S1470-2045(22)00656-8","article-title":"5-year outcomes after stereotactic ablative body radiotherapy for primary renal cell carcinoma: an individual patient data meta-analysis from IROCK","volume":"23","author":"Siva","year":"2022","journal-title":"Lancet Oncol"},{"key":"2026080510413016300_ref19","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.juro.2012.12.102","article-title":"10-year oncologic outcomes after laparoscopic and open partial nephrectomy","volume":"190","author":"Lane","year":"2013","journal-title":"J Urol"},{"key":"2026080510413016300_ref20","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.eururo.2010.12.013","article-title":"A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma","volume":"59","author":"Poppel","year":"2011","journal-title":"Eur Urol"},{"key":"2026080510413016300_ref21","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.eururo.2014.12.028","article-title":"Comparison of perioperative outcomes between robotic and laparoscopic partial nephrectomy: a systematic review and meta-analysis","volume":"67","author":"Choi","year":"2015","journal-title":"Eur Urol"},{"key":"2026080510413016300_ref22","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.urology.2012.10.067","article-title":"Perioperative complications of robot-assisted partial nephrectomy: analysis of 886 patients at 5 United States centers","volume":"81","author":"Tanagho","year":"2013","journal-title":"Urology."},{"key":"2026080510413016300_ref23","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s00270-014-0846-9","article-title":"Systematic review and meta-analysis of thermal ablation versus surgical nephrectomy for small renal tumours","volume":"37","author":"Katsanos","year":"2014","journal-title":"Cardiovasc Intervent Radiol"},{"key":"2026080510413016300_ref24","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1111\/bju.12349","article-title":"Radiofrequency ablation (RFA) of renal cell carcinoma (RCC): experience in 200 tumours","volume":"113","author":"Wah","year":"2014","journal-title":"BJU Int"},{"key":"2026080510413016300_ref25","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.eururo.2016.08.039","article-title":"Cryoablation versus partial nephrectomy for clinical T1b renal tumors: a matched group comparative analysis","volume":"71","author":"Caputo","year":"2017","journal-title":"Eur Urol"},{"key":"2026080510413016300_ref26","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1007\/s00330-018-5660-3","article-title":"Partial nephrectomy versus ablative techniques for small renal masses: a systematic review and network meta-analysis","volume":"29","author":"Uhlig","year":"2019","journal-title":"Eur Radiol"},{"key":"2026080510413016300_ref27","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.eururo.2012.08.062","article-title":"Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma","volume":"63","author":"Psutka","year":"2013","journal-title":"Eur Urol"},{"key":"2026080510413016300_ref28","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1002\/cncr.31156","article-title":"Pooled analysis of stereotactic ablative radiotherapy for primary renal cell carcinoma: a report from the international radiosurgery oncology consortium for kidney (IROCK)","volume":"124","author":"Siva","year":"2018","journal-title":"Cancer."},{"key":"2026080510413016300_ref29","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/bju.13811","article-title":"Stereotactic ablative body radiotherapy for inoperable primary kidney cancer: a prospective clinical trial","volume":"120","author":"Siva","year":"2017","journal-title":"BJU Int"},{"key":"2026080510413016300_ref30","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.eururo.2015.02.001","article-title":"Five-year analysis of a multi-institutional prospective clinical trial of delayed intervention and surveillance for small renal masses: the DISSRM registry","volume":"68","author":"Pierorazio","year":"2015","journal-title":"Eur Urol"},{"key":"2026080510413016300_ref31","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1002\/cncr.26369","article-title":"Small renal masses progressing to metastases under active surveillance: a systematic review and pooled analysis","volume":"118","author":"Smaldone","year":"2012","journal-title":"Cancer."},{"key":"2026080510413016300_ref32","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.eururo.2011.03.030","article-title":"Active surveillance of small renal masses: progression patterns and outcomes","volume":"60","author":"Jewett","year":"2011","journal-title":"Eur Urol"},{"key":"2026080510413016300_ref33","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.eururo.2020.06.053","article-title":"Small renal mass surveillance: histology-specific growth rates in a biopsy-characterized cohort","volume":"78","author":"Finelli","year":"2020","journal-title":"Eur Urol"},{"key":"2026080510413016300_ref34","doi-asserted-by":"publisher","first-page":"5457","DOI":"10.1245\/s10434-024-15431-5","article-title":"Sarcomatoid dedifferentiation as a predictor of cancer-specific mortality in surgically treated localized renal cell carcinoma","volume":"31","author":"Incesu","year":"2024","journal-title":"Ann Surg Oncol"},{"key":"2026080510413016300_ref35","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1097\/JU.0000000000001575","article-title":"Outcomes of active surveillance for young patients with small renal masses: prospective data from the DISSRM registry","volume":"205","author":"Metcalf","year":"2021","journal-title":"J Urol"},{"key":"2026080510413016300_ref36","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.juro.2018.02.3087","article-title":"Cystic renal cell carcinoma: a report on outcomes of surgery and active surveillance in patients retrospectively identified on pretreatment imaging","volume":"200","author":"Kashan","year":"2018","journal-title":"J Urol"},{"key":"2026080510413016300_ref37","doi-asserted-by":"publisher","first-page":"100244","DOI":"10.1016\/j.soi.2026.100244","article-title":"Tumor hilar proximity may be predictive of recurrence, survival, stage, and grade in patients with renal cell carcinoma. Surgical oncology","volume":"3","author":"Lahiji","year":"2026","journal-title":"Insight."},{"key":"2026080510413016300_ref38","doi-asserted-by":"publisher","first-page":"3944","DOI":"10.3390\/jcm11143944","article-title":"Quality of life and psychological distress among patients with small renal masses","volume":"11","author":"Vartolomei","year":"2022","journal-title":"J Clin Med"},{"key":"2026080510413016300_ref39","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/S1470-2045(06)70803-8","article-title":"Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study","volume":"7","author":"Huang","year":"2006","journal-title":"Lancet Oncol"},{"key":"2026080510413016300_ref40","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N Engl J Med"},{"key":"2026080510413016300_ref41","doi-asserted-by":"publisher","first-page":"664","DOI":"10.23736\/S2724-6051.25.06447-X","article-title":"Open and minimally-invasive partial nephrectomy or thermal ablation for localized renal tumors in the United States: insurance claims data on perioperative outcomes and healthcare costs","volume":"77","author":"Del Giudice","year":"2025","journal-title":"Minerva Urol Nephrol"},{"key":"2026080510413016300_ref42","doi-asserted-by":"publisher","first-page":"e353","DOI":"10.1016\/j.clgc.2022.03.011","article-title":"Cost effectiveness analysis of radiofrequency ablation (RFA) versus stereotactic body radiotherapy (SBRT) for early stage renal cell carcinoma (RCC)","volume":"20","author":"Donovan","year":"2022","journal-title":"Clin Genitourin Cancer"},{"key":"2026080510413016300_ref43","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.juro.2011.09.055","article-title":"The cost-effectiveness of immediate treatment, percutaneous biopsy and active surveillance for the diagnosis of the small solid renal mass: evidence from a Markov model","volume":"187","author":"Heilbrun","year":"2012","journal-title":"J Urol"},{"key":"2026080510413016300_ref44","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/JU.0000000000001911","article-title":"Renal mass and localized renal cancer: evaluation, management, and follow-up: AUA guideline: part I","volume":"206","author":"Campbell","year":"2021","journal-title":"J Urol"},{"key":"2026080510413016300_ref45","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1097\/JU.0000000000001912","article-title":"Renal mass and localized renal cancer: evaluation, management, and follow-up: AUA guideline: part II","volume":"206","author":"Campbell","year":"2021","journal-title":"J Urol"},{"key":"2026080510413016300_ref46","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.eururo.2025.02.020","article-title":"European Association of Urology guidelines on renal cell carcinoma: the 2025 update","volume":"87","author":"Bex","year":"2025","journal-title":"Eur Urol"},{"key":"2026080510413016300_ref47","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1200\/JCO.2016.69.9645","article-title":"Management of Small Renal Masses: American Society of Clinical Oncology clinical practice guideline","volume":"35","author":"Finelli","year":"2017","journal-title":"J Clin Oncol"},{"key":"2026080510413016300_ref48","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.annonc.2024.05.537","article-title":"Renal cell carcinoma: ESMO clinical practice guideline for diagnosis, treatment and follow-up","volume":"35","author":"Powles","year":"2024","journal-title":"Ann Oncol"},{"key":"2026080510413016300_ref49","doi-asserted-by":"publisher","first-page":"71","DOI":"10.6004\/jnccn.2022.0001","article-title":"Kidney cancer, version 3.2022, NCCN clinical practice guidelines in oncology","volume":"20","author":"Motzer","year":"2022","journal-title":"J Natl Compr Canc Netw"},{"key":"2026080510413016300_ref50","doi-asserted-by":"publisher","DOI":"10.1590\/s1677-5538.ibju.2025.0203","article-title":"Management of Small Renal Masses: literature and guidelines review","volume":"51","author":"Silvestri","year":"2025","journal-title":"Int Braz J Urol"},{"key":"2026080510413016300_ref51","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nrurol.2017.33","article-title":"Kidney cancer: emerging guidelines for managing small renal masses","volume":"14","author":"Ristau","year":"2017","journal-title":"Nat Rev Urol"},{"key":"2026080510413016300_ref52","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1089\/end.2022.0840","article-title":"A review of the recommendations and strength of evidence for clinical practice guidelines on the management of small renal masses","volume":"37","author":"Jiang","year":"2023","journal-title":"J Endourol"},{"key":"2026080510413016300_ref53","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.urolonc.2022.11.024","article-title":"Renal functional and cardiovascular outcomes of partial nephrectomy versus radical nephrectomy for renal tumors: a systematic review and meta-analysis","volume":"41","author":"Ochoa-Arvizo","year":"2023","journal-title":"Urol Oncol"},{"key":"2026080510413016300_ref54","doi-asserted-by":"publisher","first-page":"5324","DOI":"10.1007\/s00330-025-11480-w","article-title":"Image-guided percutaneous ablative treatments for renal cell carcinoma","volume":"35","author":"Auer","year":"2025","journal-title":"Eur Radiol"},{"key":"2026080510413016300_ref55","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1148\/radiol.11091207","article-title":"Percutaneous ablation in the kidney","volume":"261","author":"Venkatesan","year":"2011","journal-title":"Radiology."},{"key":"2026080510413016300_ref56","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1016\/j.juro.2015.11.029","article-title":"Diagnostic accuracy and risks of biopsy in the diagnosis of a renal mass suspicious for localized renal cell carcinoma: systematic review of the literature","volume":"195","author":"Patel","year":"2016","journal-title":"J Urol"},{"key":"2026080510413016300_ref57","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1001\/jama.281.17.1628","article-title":"Rising incidence of renal cell cancer in the United States","volume":"281","author":"Chow","year":"1999","journal-title":"JAMA."},{"key":"2026080510413016300_ref58","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3322\/canjclin.57.1.43","article-title":"Cancer statistics, 2007","volume":"57","author":"Jemal","year":"2007","journal-title":"CA Cancer J Clin"},{"key":"2026080510413016300_ref59","doi-asserted-by":"publisher","first-page":"3119","DOI":"10.1002\/cncr.25184","article-title":"Active treatment of localized renal tumors may not impact overall survival in patients aged 75 years or older","volume":"116","author":"Lane","year":"2010","journal-title":"Cancer."},{"key":"2026080510413016300_ref60","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.eururo.2013.03.034","article-title":"Management of localized kidney cancer: calculating cancer-specific mortality and competing risks of death for surgery and nonsurgical management","volume":"65","author":"Sun","year":"2014","journal-title":"Eur Urol"},{"key":"2026080510413016300_ref61","doi-asserted-by":"publisher","first-page":"e919","DOI":"10.1097\/01.JU.0000556892.23822.b5","article-title":"Active surveillance vs nephron-sparing surgery for small renal mass in very elderly patients: a competing risk analysis","volume":"201","author":"Mir Maresma","year":"2019","journal-title":"J Urol"},{"key":"2026080510413016300_ref62","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.eururo.2021.11.002","article-title":"A clinical decision aid to support personalized treatment selection for patients with clinical T1 renal masses: results from a multi-institutional competing-risks analysis","volume":"81","author":"Psutka","year":"2021","journal-title":"Eur Urol"},{"key":"2026080510413016300_ref63","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/S0022-5347(01)65167-X","article-title":"Lymphatogenous spread of renal cell carcinoma: an autopsy study","volume":"157","author":"Johnsen","year":"1997","journal-title":"J Urol"}],"container-title":["Japanese Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jjco\/article-pdf\/56\/8\/931\/68203415\/hyag069.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jjco\/article-pdf\/56\/8\/931\/68203415\/hyag069.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T14:41:41Z","timestamp":1785940901000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jjco\/article\/56\/8\/931\/8666569"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,2]]},"references-count":63,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,5,2]]},"published-print":{"date-parts":[[2026,8,5]]}},"URL":"https:\/\/doi.org\/10.1093\/jjco\/hyag069","relation":{},"ISSN":["1465-3621"],"issn-type":[{"value":"1465-3621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,8]]},"published":{"date-parts":[[2026,5,2]]}}}